SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
Elevance Health Inc. (ANTM) trades at a trailing P/E of 19.1. Trailing earnings yield is 5.22%.
Criteria proven by this page:
- VALUE (67/100, Pass) — P/E is below market average (19.1); earnings yield beats bond yields (5.22%).
- Trailing Earnings Yield 5.22% — exceeds typical bond yields (~4.3%), making equity attractive vs fixed income.
- Analyst consensus target $529.05 (+9.6% upside) — modest upside expected.
Overall SharesGrow Score: 72/100 with 5/7 criteria passed.
SharesGrow 7-Criteria Score
✓
VALUE
67/100
Price-to-Earnings & upside
Proven by this page
✓
HEALTH
100/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — ANTM
Valuation Multiples
P/E (TTM)19.1
Forward P/EN/A
PEG RatioN/A
Forward PEGN/A
P/B Ratio0.00
P/S Ratio0.59
EV/EBITDA0.0
Per Share Data
EPS (TTM)$25.21
Book Value / Share$0.00
Revenue / Share$818.10
FCF / Share$0.00
Yields & Fair Value
Earnings Yield5.22%
Dividend Yield0.00%
Analyst Target$529.05 (+9.6%)
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2016 |
$9.21 |
$84.98B |
$2.47B |
2.9% |
| 2017 |
$14.35 |
$90.04B |
$3.84B |
4.3% |
| 2018 |
$14.19 |
$92.11B |
$3.75B |
4.1% |
| 2019 |
$18.47 |
$104.21B |
$4.81B |
4.6% |
| 2020 |
$17.98 |
$121.87B |
$4.57B |
3.8% |
| 2021 |
$24.73 |
$138.64B |
$6.1B |
4.4% |
| 2022 |
$24.28 |
$156.6B |
$5.89B |
3.8% |
| 2023 |
$25.22 |
$171.34B |
$5.99B |
3.5% |
| 2024 |
$25.68 |
$176.81B |
$5.98B |
3.4% |
| 2025 |
$25.21 |
$199.13B |
$5.66B |
2.8% |
